Finance

Lists
Q1 2027 earnings • released • EPS beat +41.93% • Revenue beat +1.71%
See results
EL:NYSE
Estee Lauder Companies Inc
$104.77
-4.08%
(-4.46) 1D
$104.77
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EL...
Open
$112.26
High
$113.50
Low
$103.09
Mkt. cap
37.96B
Avg. vol.
3.14M
Volume
8.47M
Dividend
1.34%
Quarterly dividend
$0.35
Ex-dividend date
May 29, 2026
P/E ratio
163.33
52-wk high
$121.64
52-wk low
$66.22
EPS
$0.64
Beta
1.27
Shares outstanding
247.29M
No. of employees
42K
Open
$112.26
High
$113.50
Low
$103.09
Mkt. cap
37.96B
Avg. vol.
3.14M
Volume
8.47M
Dividend
1.34%
Quarterly dividend
$0.35
Ex-dividend date
May 29, 2026
P/E ratio
163.33
52-wk high
$121.64
52-wk low
$66.22
EPS
$0.64
Beta
1.27
Shares outstanding
247.29M
No. of employees
42K
News stories
From web sources and news partners
Profile
The Estée Lauder Companies Inc. is an American multinational cosmetics company, a manufacturer and marketer of makeup, skincare, perfume, and hair care products, based in Midtown Manhattan, New York City. It is the second largest cosmetics company in the world after L'Oréal. The company owns a diverse portfolio of brands, including La Mer, Jo Malone London, Clinique and Tom Ford Beauty, among many more, distributed internationally through both digital commerce and retail channels. Wikipedia
About Estee Lauder Companies Inc
CEOStéphane de La Faverie
Employees41.8K
Founded1946
HeadquartersNew York, New York, United States
SectorPersonal care products
Websiteelcompanies.com
Analyst ratings
Based on 21 analysts giving stock ratings to EL in the past 3 months
Buy
Buy
11
Hold
10
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for EL in the last 3 months.
Highest
Current $104.77
$125.00 (+19.31%)
Average
$112.71 (+7.58%)
Lowest
$92.00 (-12.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dara Mohsenian
Morgan Stanley
Hold
Maintained
$112.00
+6.9%
11/02/2026
Christopher Carey
Wells Fargo
Hold
Maintained
$110.00
+5%
11/02/2026
Lauren Lieberman
Barclays
Buy
Maintained
$108.00
+3.1%
11/02/2026
Nik Modi
RBC Capital
Buy
Maintained
$120.00
+14.5%
10/29/2026
Robert Ottenstein
Evercore ISI
Buy
Maintained
$125.00
+19.3%
10/28/2026
Ashley Wallace
Bank of America Securities
Buy
Reiterated
$120.00
+14.5%
10/26/2026
Anna Andreeva
Piper Sandler
Buy
Reiterated
$125.00
+19.3%
10/23/2026
Susan Anderson
Canaccord Genuity
Hold
Maintained
$109.00
+4%
10/22/2026
Sydney Wagner
Jefferies
Hold
Maintained
$120.00
+14.5%
10/19/2026
Andrea Faria Teixeira
J.P. Morgan
Buy
Maintained
$115.00
+9.8%
10/19/2026
Bonnie Herzog
Goldman Sachs
Buy
Reiterated
$124.00
+18.4%
10/16/2026
Peter Grom
UBS
Hold
Reiterated
$104.00
-0.7%
10/15/2026
Filippo Falorni
Citi
Buy
Maintained
$115.00
+9.8%
10/14/2026
Cristian Rios
Bernstein
Hold
Maintained
$106.00
+1.2%
10/08/2026
Olivia Tong
Raymond James
Buy
Maintained
$115.00
+9.8%
10/07/2026
Stephen Powers
Deutsche Bank
Buy
Maintained
$117.00
+11.7%
09/11/2026
Unknown Analyst
CICC
Buy
Upgraded
$122.00
+16.4%
08/30/2026
Dana Telsey
Telsey Advisory
Hold
Maintained
$108.00
+3.1%
08/28/2026
Fulvio Cazzol
Berenberg Bank
Hold
Maintained
$92.00
-12.2%
08/24/2026
Unknown Analyst
Berenberg Bank
Hold
Maintained
$92.00
-12.2%
08/24/2026
Anna Glaessgen
B. Riley Securities
Hold
Maintained
$100.00
-4.6%
08/19/2026
Oliver Chen
TD Cowen
Hold
Reiterated
$100.00
-4.6%
08/20/2026
Unknown Analyst
Bernstein
Hold
Initiated
$82.00
-21.7%
06/11/2026
Andy Sim
DBS
Hold
Maintained
$88.00
-16%
05/05/2026
Jeremy Fialko
HSBC
Hold
Downgraded
$106.00
+1.2%
02/10/2026
Last report
Just released
Today, 8:30 AM
Fiscal period
Q1 2027
$0.72 / $0.51
+41.93%beat
Revenue / Est. (USD)
3.72B / 3.65B
+1.71%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.48B
4.23B
3.71B
3.63B
Cost of goods sold
929.00M
994.00M
876.00M
885.00M
Cost of revenue
929.00M
994.00M
876.00M
885.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.30B
2.63B
2.28B
2.49B
Operating expense
2.30B
2.63B
2.28B
2.49B
Total operating expenses
3.23B
3.63B
3.16B
3.37B
Operating income
253.00M
603.00M
554.00M
254.00M
Other non operating income
-
-
-
-
EBT including unusual items
109.00M
333.00M
179.00M
-104.00M
EBT excluding unusual items
197.00M
539.00M
487.00M
197.00M
Income tax expense
62.00M
171.00M
90.00M
12.00M
Effective tax rate
56.88%
51.35%
50.28%
-11.54%
Other operating expenses
-
-
-
-
Net income
47.00M
162.00M
89.00M
-116.00M
Net profit margin
1.35%
3.83%
2.40%
-3.20%
Earnings per share
0.32
0.89
0.91
0.39
Interest and investment income
30.00M
21.00M
15.00M
24.00M
Interest expense
-86.00M
-85.00M
-82.00M
-81.00M
Net interest expenses
-56.00M
-64.00M
-67.00M
-57.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
453.00M
800.00M
755.00M
452.00M
Gain or loss from assets sale
-
3.00M
7.00M
16.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps